Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet
- 1 December 2015
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 115 (6) , 509-515.e2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- How molecular diagnosis can change allergen‐specific immunotherapy prescription in a complex pollen areaAllergy, 2012
- Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapyJournal of Allergy and Clinical Immunology, 2012
- Allergen immunotherapy: A practice parameter third updateJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adultsJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsJournal of Allergy and Clinical Immunology, 2011
- Molecular diagnosis in allergyClinical & Experimental Allergy, 2010
- Key pollen allergens in North AmericaAnnals of Allergy, Asthma & Immunology, 2003
- Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen‐specific serum immunoglobulin EClinical & Experimental Allergy, 2003
- Utility of food-specific IgE concentrations in predicting symptomatic food allergyJournal of Allergy and Clinical Immunology, 2001
- Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescentsJournal of Allergy and Clinical Immunology, 1997